NCT05089721

Brief Summary

The research was planned as a face-to-face survey evaluation. The questionnaire will be applied to obstetricians and anesthesiologists working in public and private hospitals. The universe of the research will be selected by simple random sampling method, and the total number of people who will participate is planned to be 200, approximately 100 from each of the two branches. Our survey consists of 5 parts structurally. Demographic data, rate of cesarean section and postpartum hemorrhage, uterotonic agent preferences in low/high risk cesarean section surgeries, the preference for second-line uterotonic agents, and the dose preferences of uterotonic agents.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 11, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 22, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

May 21, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 21, 2022

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 21, 2025

Completed
Last Updated

January 3, 2025

Status Verified

January 1, 2024

Enrollment Period

4 months

First QC Date

October 11, 2021

Last Update Submit

January 1, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Uterotonic usage habits in postpartum hemorrhage

    to learn the uterotonic use preferences of both obstetricians and anesthesiologists in postpartum

    3 months

Secondary Outcomes (1)

  • Uterotonic usage habits in elective cesearean section

    3 months

Study Arms (2)

Anesthesiologist

Obstetricians

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Through national obstetrics and anesthesiologist associations, the survey will be sent to the participant's e-mail addresses. Those who answer the questionnaire will be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University School of Medicine

Ankara, Ankara, 06500, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Uterine HemorrhageUterine Inertia

Condition Hierarchy (Ancestors)

Uterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsDystociaObstetric Labor ComplicationsPregnancy Complications

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor in Department of Anesthesiology and Reanimation

Study Record Dates

First Submitted

October 11, 2021

First Posted

October 22, 2021

Study Start

May 21, 2022

Primary Completion

September 21, 2022

Study Completion

February 21, 2025

Last Updated

January 3, 2025

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

overall results of survey will be shared, individual answers of participants wont be shared

Locations